About
Matthew Reber joined 1315 Capital as a Partner in 2017, having previously spent nine years at HealthCare Royalty Partners, where he was a Managing Director, along with earlier roles at Accretive LLC, Paul Capital Partners, Oak Hill Capital Partners, J.H. Whitney & Co., and Morgan Stanley. His investing work focuses on the pharma/medtech outsourcing and pharma/medtech product sectors. He holds a BSc in Engineering from Princeton University, an MBA from The Wharton School, and a Master of Biotechnology from the University of Pennsylvania.
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
Coating PlaceCodisExpericMedivant HealthcarePrimrose BioProScientoReaction BiologySciSafeUSpharmaVerogen
Per the firm's website.
Colleagues at 1315 Capital
Adele C. Oliva
Founding Partner at 1315 Capital
Brian Schwenk
CFO and CCO at 1315 Capital
Craig Matturro
Principal at 1315 Capital
Ian B. Li
Principal at 1315 Capital
Jacqueline Akpan
Controller at 1315 Capital
Jake Baker
Business Development Associate at 1315 Capital
Jamie Richardson
Director of Business Development at 1315 Capital
Joe Schlitz
Associate at 1315 Capital